English | Español

Regulatory
+ Regulatory
Michael McGrady | Jun 12, 2017

Federal agencies continue to implement National Pain Strategy over one year later
+ Technology/Innovation
Nicholas Gueguen | Jun 11, 2017

Astellas and Seattle Genetics unveil enfortumab vetodin Phase 1 testing data
+ Technology/Innovation
Robert Hadley | Jun 11, 2017

Harvard Medical School study pairs nanoparticles, radiation to fight cancer
+ Technology/Innovation
Robert Hadley | Jun 11, 2017

Study links segregation to higher blood pressure among black adults
+ Regulatory
Nicholas Gueguen | Jun 11, 2017

European Commission OKs Spinraza to fight spinal muscular atrophy
+ Regulatory
Robert Hadley | Jun 11, 2017

GlaxoSmithKline submits single-tablet, dual-drug HIV regimen for FDA approval
+ Technology/Innovation
Ruth de Jauregui | Jun 10, 2017

Bristol-Myers Squibb says Phase II of Sprycel in pediatric chronic myeloid leukemia cases shows promise
+ Technology/Innovation
Ruth de Jauregui | Jun 10, 2017

Amgen says Xgeva trial shows promise as option for patients with multiple myeloma

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes